SkinBioTherapeutics (GB:SBTX) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
In a significant update from SkinBioTherapeutics PLC, David Campbell Brierwood has crossed a threshold in voting rights, now holding 3.1% of the company with 6,998,305 total voting rights as of August 12, 2024. This change in shareholding structure was formally notified to the company on the following day. No voting rights are held through financial instruments, indicating a straightforward equity stake.
For further insights into GB:SBTX stock, check out TipRanks’ Stock Analysis page.
